Jinghuaweikang capsules combined with triple therapy in the treatment of Helicobacter pylori associated gastritis and duodenal ulcer and analysis of antibiotic resistance: a multicenter, randomized, controlled, clinical study

National Medical Journal of China

Volumn 92, Issue 10, 2012, Pages 679-684

  Hu, Fu Lian ^a   Cheng, Hong ^a   Zhang, Xue Zhi ^b   An, He Juan ^b   Sheng, Jian Qiu ^b   Lü, Nong Hua ^b   Xie, Yong ^b   Chen, Zhi Shui ^b   Xu, Jian Ming ^b   Hu, Nai Zhong ^b   Zheng, Peng Yuan ^b   Zhang, Li ^b   Zhang, Ling Xia ^b   Zhang, Sheng Sheng ^b   Tao, Lin ^b   Zhang, Zhen Yu ^b   Cui, Mei Hua ^b   Yang, Gui Bin ^b   Wang, Bang Mao ^b   Jiang, Kui ^b   Yang, Qiang ^b   Gao, Heng Jun ^b   more..

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b NONE

Author keywords

CHINESE PATENT DRUGS; Drug resistance; Drug therapy, combination; Helicobacter pylori

Indexed keywords

AMOXICILLIN PLUS CLARITHROMYCIN PLUS LANSOPRAZOLE; ANTIBIOTIC AGENT; BISMUTH CITRATE; CHINESE DRUG; JINGHUAWEIKANG; UNCLASSIFIED DRUG; UREA C 13;

ABDOMINAL PAIN; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BLOATING; CONTROLLED STUDY; DIGESTIVE TRACT ENDOSCOPY; DRUG CAPSULE; DRUG EFFICACY; DRUG TREATMENT FAILURE; DUODENUM ULCER; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NONHUMAN; RANDOMIZED CONTROLLED TRIAL; STOMACH MUCOSA; SYMPTOM; TREATMENT DURATION; UREA BREATH TEST;

ADULT; DRUG RESISTANCE, BACTERIAL; DRUGS, CHINESE HERBAL; DUODENAL ULCER; FEMALE; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84868266224     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2012.10.012     Document Type: Article

References (18)

1. Miwa H, Sakaki N, Sugano K, et al. Recurrent peptic ulcers in patients following successful Helicobacter pylori eradication: a multicenter study of 4940 patients. Helicobacter, 2004, 9: 9-16.
2. Wong B C, Lam S K, Wong W M, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA, 2004, 291:187-194.
3. 2005, 85:2754-2757.
4. Gao W, Cheng H, Hu F, et al. The evolution of Helicobacter pylori antibiotics resistance over 10 years in Beijing, China. Helicobacter, 2010, 15: 460-466.
5. 2006, 86:2679-2682.
6. 2007, 12: 531-534.
7. Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut, 2007, 56:772-781.
8. 2008, 88: 652-656.
9. De Luca L, Zagari R M, Pozzato P, et al. Measuring dyspepsia: a new severity index validated in Bologna. Dig Liver Dis, 2004, 36: 806-810.
10. 2010, 18: 163-166.
11. 2001, 10:221-223.
12. 2006, 15:522-524.
13. 2006, 15: 1354-1356.
14. 2010, 18:290-293.
15. 2006, 26:517-520.
16. 2009, 17: 50-51.
17. 2006, 15:1874-1876.
18. 2008, 17:543-546.